Epidemiological clinical characterization of patients with tumoral pelvic inflammatory disease

Authors

Keywords:

absceso pélvico, adolescente, enfermedad inflamatoria pélvica tumoral, absceso tubo- ovárico.

Abstract

Introduction: Pelvic inflammatory disease is the most frequent serious infection in women between 16 and 25 years old. Adolescence is the period of highest risk of onset due to the higher incidence of risk factors related to unsafe sexual behaviors. Objective: To determine the clinical and epidemiological characteristics of patients diagnosed with tumoral pelvic inflammatory disease.
Methods: We worked with a population of 63 patients. Two study groups were formed, group I with adolescents and young people, and group II with the other patients. The variables used were: early sexual intercourse, number of sexual partners, unprotected intercourse, use of intrauterine devices, history of pregnancy termination, main clinical manifestations, complementary results, and treatment administered.
Results: It was found that 76.4% of the adolescents had unprotected sexual relations, 52.9% began sexual relations before the age of 14, 64.7% referred a history of induced abortions, and 100% requested attention for pain pelvic. Medical treatment was used in 95.6% of the patients.
Conclusions: In most of the cases, the clinical and complementary symptoms performed were consistent with tumor pelvic inflammatory disease; and the treatment used was medical.

Downloads

Download data is not yet available.

References

1. Kim HY, Yang JI, Moon C. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess. J ObstetGynaecol Res. 2015 [acceso: 26/2/2020]; 41(5):742-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25363239

2. Baquedano Mainar L, Lamarca Ballestero M, Puig Ferrer F, Ruiz Conde MA. Enfermedad inflamatoria pélvica: un reto en el diagnóstico y tratamiento precoz. RevChilObstetGinecol. 2014 [acceso: 14/9/2018]; 79(2):115-20. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262014000200009&lng=es

3. Álvarez-Pabón Y, Sepúlveda-Agudelo J, Díaz-Martínez LA. Enfermedad pélvica inflamatoria: análisis retrospectivo. GinecolObstet Méx. 2017 [acceso: 13/9/2018]; 85(7):433-441. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0300-90412017000700433&lng=es

4. Vázquez Valerio L. Enfermedad pélvica inflamatoria. Rev Revista Médica Sinergia.2017 [acceso:13/9/2019]; 2(12):11-4. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/102/165

5. Xholli A, Cannoletta M, Cagnacci A. Seasonal trend of acute pelvic inflammatory disease. ArchGynecolObs. 2014 [acceso:13/9/2018]; 289: 1017-22. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24258789

6. Terao M, Koga K, Shiro K ,Yosuga Y, Yano T. Factors that predict poor clinical course among patients hospitalized with Pelvic inflammatory disease. J ObsGynaecol Res. 2014[acceso:14/2/2020]; 40(2):495-500. Disponible en: https://www.semanticscholar.org/paper/Factors-that-predict-poor-clinical-course-among-Terao-Koga/463d15ae2630b6addc34eba622817693c590e148

7. Zeledón Rojas N. Enfermedad pélvica inflamatoria. RevMédSinerg. 2016 [acceso: 9/3/2020];1(12):3-9. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/53

8. Vargas Celaya DA. Enfermedad pélvica inflamatoria. Revista médica de Costa Rica y Centroamérica. 2014[acceso: 9/3/2020];LXXI(612):719-722. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2014/rmc144q.pdf

9. Barrantes Rodríguez S. Enfermedad pélvica inflamatoria. Revista Médica de Costa Rica y Centroamérica. 2015 [acceso: 19/2/2020]; LXXII (614):105-9. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2015/rmc151u.pdf

10. Alarcón-Villaverde J, Ramos-Castillo J. Infecciones en ginecología y obstetricia: producción científica de la Sociedad Peruana de Obstetricia y Ginecología en sus setenta años de vida institucional. RevPeruGinecolObstet. 2017 [acceso: 9/3/2020]; 63(3):429-47. Disponible en: https://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322017000300014&lng=es

11. Reckart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J InfectDis.2013 [acceso: 19/2/2020];207(1):30-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23100568

12. Martínez Camilo V, Vanegas Estrada R. Enfermedad inflamatoria pélvica tumoral en adolescentes. RevCubanaObstetGinecol. 2002 [acceso 21/7/2019]; 28(2):[aprox. 6 p.].Disponible en: https://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0138-600X2002000200008&lng=es&nrm=iso

13. Santana Suárez MA, Suárez Suárez B, Ocón Padrón L, Seara Fernández S. Diagnóstico y tratamiento de la enfermedad pélvica inflamatoria. Clínica e Investigación en Ginecología y Obstetricia. 2018[acceso: 9/3/ 2020]; 45(4):157-62. Disponible en: https://www.elsevier.es/es-revista-clinica-e-investigacion-ginecologia-obstetricia-7-avance-resumen-diagnostico-tratamiento-enfermedad-pelvica-inflamatoria-S0210573X17300345

14. Asociación Médica Mundial (AMM). Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. Fortaleza, Brasil: AMM; 2013. [acceso: 18/04/2020]. Disponible en: https://repositorio.mederi.com.co/bitstream/handle/123456789/386/Declaracion-Helsinki-2013-Esp.pdf?sequence=1

15. García Roche R G, Cortés Alfaro A, Vila Aguilera LE, Hernández Sánchez M, Mesquia Valera A. Relaciones sexuales y uso del preservativo en adolescentes y jóvenes de un área de salud. RevCubanaMed Gen Integr. 2006 [acceso: 21/3/2019]; 22(1): [aprox. 7p.]. Disponible: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252006000100003

16. Peláez Mendoza Jorge. El uso de métodos anticonceptivos en la adolescencia. RevCubanaObstetGinecol. 2016 [acceso: 21/3/2020];42(1): [aprox. 7p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2016000100011&lng=es

17. García León L, Mendoza José R, Herrera Llerena N, Núñez A. Valor de la ultrasonografía abdominal en la enfermedad inflamatoria pélvica. RevCubanaObstetGinecol. 2001[acceso 9/3/2020]; 27(1):12-5. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2001000100002&lng=es

18. Torriente-Vizcaíno L. Caracterización de adolescentes ingresadas en el servicio de Ginecología (2011- 2013). Revista Cubana de Obstetricia y Ginecología. 2016 [acceso: 12/3/ 2019];42(2):147-57. Disponible en: https://scielo.sld.cu/pdf/gin/v42n2/gin01216.pdf

Downloads

Published

2021-02-04

How to Cite

1.
Urgellés Carreras SA, Álvarez Fiallo M, Ramos Zamora V, Reyes Guerrero E. Epidemiological clinical characterization of patients with tumoral pelvic inflammatory disease. Rev Cubana Med Milit [Internet]. 2021 Feb. 4 [cited 2025 May 9];50(1):e0210714. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/714

Issue

Vol. 50 No. 1 (2021): January - March

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.